The Peptide Podcast cover art

The Peptide Podcast

The Peptide Podcast

By: The Peptide Queen
Listen for free

About this listen

 The Peptide Podcast makes health and wellness decisions SIMPLE, FAST, and FUN. In less than 15 minutes each weekday, you’ll get accurate, unbiased updates on peptides—from disease prevention and performance health to anti-aging and more. Hosted by The Peptide Queen, a clinical pharmacist with more than 15 years of experience, the show cuts through internet confusion to give you clear, reliable information so you can choose what’s best for you.This website and its content are copyright of The Peptide Podcast - All rights reserved. Any redistribution or reproduction of part or all of the contents in any form is prohibited. Alternative & Complementary Medicine Exercise & Fitness Fitness, Diet & Nutrition Hygiene & Healthy Living
Episodes
  • GLOW Peptide Therapy

    GLOW Peptide Therapy
    Oct 2 2025
    I’m so glad you’re here today because we’re diving into a therapy that people are buzzing about—GLOW peptide therapy. If you want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going. https://pepties.com/partners/ Now, you’ve probably heard me talk about individual peptides before, but this one’s a peptide stack—a combination of three peptides that are designed to work together. And honestly, the name says it all. People who use this blend often say they recover faster, their skin looks healthier, and they just feel better overall. That’s why it’s called GLOW. So today, I’m going to walk you through what GLOW peptide therapy is, what’s actually in it, how each of these peptides work, typical dosing, cycles, side effects, who should avoid it, and finally—I’ll go through some of the most common questions people ask. The Three Peptides in GLOW GLOW therapy combines BPC-157, TB-500 or thymosin beta-4, and GHK-Cu. Each one does something unique, but when you put them together, you get this synergistic effect that’s bigger than the sum of its parts. Let’s start with BPC-157. This peptide is naturally derived from something we all have in our stomach lining—it’s literally called the body protection compound. And the name fits. It helps protect and repair tissue, calm down inflammation, and even support gut health. A lot of people first hear about BPC-157 because athletes use it for muscle strains, tendon injuries, or joint pain. But it’s also been studied for gut issues like ulcers and leaky gut. The magic is in how it helps new blood vessels form so your tissues can actually heal faster and stronger. The next thing I want to touch on is that the GLOW peptide stack sometimes lists TB-500 or Thymosin Beta-4 (TB4) as if they’re interchangeable. And while they’re closely related, they’re not exactly the same. Both of them are best known for their role in healing and recovery. They guide cells to the site of an injury, help reduce scar tissue, improve blood flow by encouraging new blood vessel growth, and calm down excess inflammation so real healing can happen. Where they start to differ is in their scope of action. Thymosin Beta-4 is the full-length, naturally occurring peptide — the master version, if you will. Because it’s the entire chain, it interacts with more pathways and has been studied in a wide range of areas: wound healing, heart repair after a heart attack, corneal healing, brain and nerve protection, even immune system regulation. TB-500, on the other hand, is a synthetic fragment of Thymosin Beta-4. It contains the “active core” that drives cell migration and blood vessel growth. That makes it very effective for tissue repair, tendon healing, wound closure, and circulation. But it doesn’t have all the extra regulatory sections that give the full peptide those broader effects on the heart, brain, or immune system. What’s good to know, is that in practice, most formulations use TB-500 because it’s more stable (both in the body and for storage), widely available, and it’s cost-effective. Some clinics may use the full Thymosin Beta-4, but that’s far less common due to the cost of production. From a user perspective, both serve the same purpose in the stack: recovery, regeneration, and repair. However, TB-500 does not have all the broader effects that the full-length Thymosin Beta-4 peptide has. Think of it this way, TB-500 tends to be seen as more targeted — very good at tissue and tendon repair, wound closure, and improving circulation, but without the same wide-ranging effects on the heart, brain, or immune system that you see with the complete TB4 peptide. Okay, moving along to the last component of the GLOW peptide stack: GHK-Cu or the copper peptide. You might’ve already seen this one in the skincare world—creams and serums often brag about having copper peptides because they boost collagen, smooth wrinkles, and improve elasticity. But GHK-Cu is more than just cosmetic. Inside the body, it promotes wound healing, reduces inflammation, fights oxidative stress, and even supports hair regrowth. This is the peptide that really brings the “glow” to GLOW therapy. People notice their skin looks fresher and healthier, their hair feels stronger, and they just have that rejuvenated look. Now, each of these peptides—BPC-157, TB-500 or TB-4, and GHK-Cu—can be prescribed and given separately as a subcutaneous injection, and sometimes that’s the right approach depending on someone’s goals. But for convenience, they’re often combined into a single formulation or vial, which makes daily use a lot simpler. Instead of juggling three different injections, you’re working with one balanced blend that delivers the same benefits in a more streamlined way. Why Combine Them? So, why put these three together? Well, BPC-157 is ...
    Show More Show Less
    14 mins
  • How Retatrutide Compares to Semaglutide and Tirzepatide

    How Retatrutide Compares to Semaglutide and Tirzepatide
    Sep 25 2025
    Welcome to The Peptide Podcast. In this episode, we’re unpacking the latest on retatrutide and how it measures up against semaglutide and tirzepatide. If you want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going. https://pepties.com/partners/ We’ll look closely at what the studies tell us so far — from overall weight loss to reductions in visceral fat and how much lean muscle mass is preserved. We’ll also talk about where the evidence is solid, where it’s still developing, and why cross-trial comparisons should be made with caution. What is retatrutide? So let’s start with the basics—what is retatrutide? Retatrutide is a new type of weight-loss medication called a triple agonist. That sounds fancy, but what it really means is that it targets three hormone receptors in the gut and pancreas: GLP-1, GIP, and glucagon. Each of these plays a slightly different role in metabolism and appetite regulation. To break it down: GLP-1, which you might already know from drugs like semaglutide, mainly slows digestion, helps you feel full, and improves insulin sensitivity. GIP, which tirzepatide targets along with GLP-1, also helps regulate blood sugar and may improve how the body stores and burns fat. Retatrutide adds glucagon receptor activation on top of that, which seems to further boost fat burning. So how does this compare to semaglutide and tirzepatide? Semaglutide is a GLP-1-only drug, so it mainly works by reducing appetite and slowing gastric emptying. Tirzepatide is a dual agonist, hitting GLP-1 and GIP, which gives it a slightly stronger effect on blood sugar control and fat metabolism compared to semaglutide. Retatrutide goes one step further by adding glucagon activity, potentially giving more total fat loss. In other words, you can think of it like a spectrum: semaglutide hits one target, tirzepatide hits two, and retatrutide hits three—each additional receptor seems to enhance metabolic effects and fat loss in clinical trials. That’s why people are excited about retatrutide, though it’s still early, and we’re waiting on larger studies to see exactly how it compares head-to-head with the others. And that’s going to be key, since right now we don’t have direct comparisons to other advanced therapies like semaglutide or tirzepatide in the published Phase 2 data. How does retatrutide compare to semaglutide and tirzepatide? Total body weight loss: Now let’s put these three medications side by side and look at what the trials actually tell us about total body weight loss. Starting with retatrutide: in its Phase 2 obesity program, the numbers were unusually large, especially given the relatively short trial window. In the 48-week study, people on the higher doses—8 or 12 milligrams weekly—lost about 22 to 24% of their body weight on average. That’s the result that really made headlines. It’s worth noting that some trials report slightly different averages depending on the group studied—people with obesity but no diabetes versus people with type 2 diabetes—but across the board, that 48-week signal is consistently very strong. For comparison, let’s step back to semaglutide at the 2.4 mg dose, which was tested in the pivotal STEP-1 trial. Over 68 weeks, participants lost about 15% of their body weight on average. That was a landmark finding when it was published in the New England Journal of Medicine—it essentially set the modern benchmark for what a GLP-1 monotherapy could do. Then we have tirzepatide, the dual GIP and GLP-1 agonist. The SURMOUNT-1 trial, which ran for 72 weeks, showed dose-dependent results: about 15% weight loss at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg, compared to only around 3% with placebo. Other obesity studies with tirzepatide have backed this up, especially at the higher doses. And in head-to-head comparisons with semaglutide, tirzepatide has consistently come out on top. So if we zoom out: retatrutide’s Phase 2 data suggest the greatest average reductions—over 22%—in less than a year. Tirzepatide follows closely behind with around 21% over 72 weeks. And semaglutide shows very meaningful, but smaller, weight loss of around 15% over a similar time frame. The big caveat here is that these aren’t perfect apples-to-apples comparisons. The trials differed in their length, the types of patients enrolled—some had type 2 diabetes, some did not—their baseline weights, and even the way results were reported. Plus, retatrutide is still in Phase 2 for obesity, whereas semaglutide and tirzepatide already have large Phase 3 programs and real-world data backing them up. Visceral fat reduction: Next, let’s talk about visceral fat reduction—that’s the deep fat that surrounds organs like the liver, pancreas, and intestines. It’s particularly important because high levels of visceral fat are strongly linked to ...
    Show More Show Less
    15 mins
  • Pancragen

    Pancragen
    Sep 18 2025
    Today, I want to shine a light on a fascinating, little-known peptide called Pancragen. And if you want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going. https://pepties.com/partners/ Now, if you’ve been following the world of anti-aging and metabolic optimization, you probably know about GLP-1 medications, metformin, and other mainstream therapies—but Pancragen is something a bit different. It’s a tiny peptide with a big mission. That is rejuvenating your pancreas and restoring metabolic function. And trust me, the science behind it is pretty remarkable. What is Pancragen? So here’s the story—Pancragen was developed by a team of Russian researchers led by Professor Vladimir Khavinson in St. Petersburg. These are the same minds behind legendary peptides like Epitalon and Thymalin. What they discovered was pretty fascinating. In the bovine pancreas, they found a tiny tetrapeptide—just four amino acids—that acts like a molecular switch for keeping your pancreas youthful. The full sequence is Lysine, Glutamic acid, Aspartic acid, and Tryptophan. Now, in biochemistry, we usually shorten these with a one-letter code, so Lysine becomes K, Glutamic acid is E, Aspartic acid is D, and Tryptophan is W—which is why this peptide is known as KEDW. Pancragen was created to mimic that exact peptide. And over decades of studies in both animals and humans, the results have been honestly amazing. How Pancragen Works Here’s where it gets really exciting. Unlike most medicaitons that act broadly and non-specifically in the body, Pancragen is precise. When you inject it under the skin, it travels through your bloodstream straight to the pancreas. And get this—it can even enter the nucleus of pancreatic cells and interact with the DNA that controls key genes for insulin and enzyme production, like Pdx1, Ptf1a, and Pax6. Pdx1 is essential for insulin production, Ptf1a helps pancreatic cells make digestive enzymes, and Pax6 keeps the insulin-producing cells functioning properly. Basically, Pancragen flips these genes back on, helping pancreatic cells survive, grow, and work efficiently. The result? Better insulin regulation, improved enzyme production, and a pancreas that behaves years younger—think of it like updating your pancreas’s software to the latest version. What the Studies Show Let’s talk numbers. In aging patients with type 2 diabetes, Pancragen reduced fasting blood glucose by 20–25% and improved post-meal glucose even more. Even better, patients needed up to 35% less insulin for the same level of glucose control—meaning their cells became more sensitive to insulin rather than being forced to overwork. In primate studies, old monkeys treated with Pancragen actually outperformed those on glimepiride, a standard diabetes medication. Pancragen restored normal insulin and C-peptide rhythms without forcing the pancreas into burnout—and these effects lasted for weeks after treatment ended. And here’s a bonus: Pancragen also normalizes melatonin secretion, which helps improve sleep, circadian rhythm, and overall metabolic health. So it’s not just about blood sugar—it’s a full-spectrum metabolic reset. Safety and Benefits Pancragen has been on the market in Eastern Europe for over a decade with no reported toxicity or adverse interactions. It simply breaks down into regular amino acids when its job is done. Users report: More stable blood sugar and fewer hypoglycemic events Reduced insulin requirements Better digestion and enzyme function Increased energy and fewer “hangry” moments A general feeling of metabolic youthfulness/health And because it works at the gene-expression level, these benefits can last for weeks or months after a cycle of Pancragen. Who Should Consider Pancragen? So, who is Pancragen for? People with type 2 diabetes or prediabetes: Pancragen helps restore normal pancreatic function, improving insulin production and glucose control instead of just masking symptoms. Those with chronic pancreatitis or enzyme insufficiency: By supporting pancreatic cells and enzyme production, it can help the pancreas work more efficiently, which may ease digestive issues. Older adults looking for metabolic anti-aging support: Pancragen can rejuvenate pancreatic function, improve insulin sensitivity, and support overall metabolic health—essentially helping the body act younger. Athletes or high-performers wanting optimal metabolic efficiency: Better pancreatic function means more precise insulin and enzyme regulation, supporting energy, recovery, and performance. People looking to prevent a plateau from GLP-1 therapy: Over time, some GLP-1 users hit a point where their progress stalls. Pancragen may help “reset” the pancreas so therapy stays effective. But keep in mind, if you’re just after a quick appetite suppressant, Pancragen isn...
    Show More Show Less
    7 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.